Geneva, Feb. 23 -- International Clinical Trials Registry received information related to the study (ACTRN12626000192381) titled 'A study of the effect of relabotulinumtoxinA on moderate to severe forehead wrinkles in adults aged 18 to 65 years' on Feb. 16.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: The Dermatology Institute of Victoria
Condition:
Horizontal forehead rhytides
Horizontal forehead rhytides
Musculoskeletal - Other muscular and skeletal disorders
Intervention:
Eligible participants will undergo an initial (baseline) visual facial assessment to determine their ...